Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

MEDA

WKN: 935166  ISIN: SE0000221723  Ticker-Symbol: M5E 
Aktie:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDA Chart 1 Jahr
1-Woche-Intraday-Chart
MEDA 1-Woche-Intraday-Chart

Aktuelle News zur MEDA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
21.05. 39
RALEIGH, N.C., May 21, 2012 /PRNewswire/ --BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced receipt of a pre-launch milestone payment of $2.5 million from Meda in conjunction with...
Mehr lesen zu:
BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U.
10.05. 357
FOLGENDE WERTPAPIERE WERDEN AM 10.05.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.05.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT RNL XETI FR0000131906...
Mehr lesen zu:
XETI DIVIDEND INFORMATION - 10.05.2012 - 2
10.05. 482
FOLGENDE WERTPAPIERE WERDEN AM 10.05.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.05.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT ALU XFRA US0138171014...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 10.05.2012 - 5
09.05. 36
Regulatory News: At the annual general meeting (AGM) on May 9, 2012, of Meda AB (publ)(STO:MEDAA), corporate ID 556427-2812, Box 906, SE-170 09 Solna, ...
Mehr lesen zu:
Meda AB (publ) AGM bulletin
09.05. 52
Regulatory News: Meda AB(STO:MEDAA): Group net sales reached SEK 3,375 million (2,944). At fixed currency rates, sales increased...
Mehr lesen zu:
Meda AB (Publ) – Interim Report, January-March 2012
09.05. 72
FOLGENDE WERTPAPIERE WERDEN AM 09.05.2012 CUM DIVIDENDE UND AM 10.05.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 09.05.2012. THE EX-DIVIDEND DAY WILL BE 10.05.2012. ...
Mehr lesen zu:
XETI DIVIDEND INFORMATION - 10.05.2012 - 1
09.05. 363
FOLGENDE WERTPAPIERE WERDEN AM 09.05.2012 CUM DIVIDENDE UND AM 10.05.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 09.05.2012. THE EX-DIVIDEND DAY WILL BE 10.05.2012. ...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 10.05.2012 - 2
04.05. 35
Regulatory News: Meda AB (STO:MEDAA): The renowned Journal of Allergy and Clinical Immunology ((JACI;2012;129:1282–9) published an article...
Mehr lesen zu:
MEDA: Dymista – could be the drug of choice
02.05. 60
Regulatory News: The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR)....
Mehr lesen zu:
MEDA: Dymista approved by the FDA
17.04. 63
Regulatory News: Maria Carell (STO:MEDAA), board member of Meda AB since 2011, has informed Meda's nomination committee that she declines re-election at ...
Mehr lesen zu:
Maria Carell Declines Re-Election to the Board of Meda
17.04. 71
Regulatory News: Maria Carell has been appointed Regional Director for Meda's (STO:MEDAA) operations in the US. Maria Carell has extensive experience in the...
Mehr lesen zu:
MEDA: Maria Carell Appointed Regional Director for the US
05.04. 21
03.04. 31
Regulatory News: Notice is hereby given that the Annual General Meeting (AGM) of Meda AB (STO:MEDAA), corporate ID 556427-2812, will be held at 5.00 PM on...
Mehr lesen zu:
Meda AB (publ) Notice of Annual General Meeting 2012
03.04. 54
Regulatory News: Meda (STO:MEDAA) has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda...
Mehr lesen zu:
Meda Expands Presence in Asia
23.03. 93
Regulatory News: The Nomination Committee of Meda AB (STO:MEDAA) proposes the election of Lars Westerberg as new board member. The committee also proposes...
Mehr lesen zu:
MEDA: Nomination Committee's Proposal to Composition of the Board
20.03. 40
Regulatory News: Astepro (STO:MEDAA) has received registration approval in Europe via the decentralized procedure. Astepro is a new nasal spray for the treatment...
Mehr lesen zu:
MEDA: Astepro Approved in Europe
05.03. 86
Regulatory News: Meda (STO:MEDAA) announced today positive results of three studies of MP29-02 (tentatively called Dymista), a novel intranasal formulation...
Mehr lesen zu:
MEDA: Positive results for Dymista in three clinical studies
17.02. 70
Regulatory News: MEDA (STO:MEDAA): · Group net sales reached SEK 12,856 million (11,571). At fixed currency rates, sales increased 18%. ...
Mehr lesen zu:
Meda AB (publ) – Year-end report 2011
23.01. 2
23.01. 61
ALLEGAN, Mich., Jan. 23, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug...
Mehr lesen zu:
Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals
Seite: 1 2 Weiter>>
24 Nachrichten in den letzten 6 Monaten